Pfizer Inc.
Time frame: 1 February 2023 - 31 January 2024Article ‘Count’ and ‘Share’ for Pfizer Inc. based on listed parameters only.
The articles listed below published by authors from Pfizer Inc., organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
Annals of the Rheumatic Diseases |
2 | 0.77 |
Blood |
1 | 0.56 |
Chest |
1 | 0.10 |
Clinical Infectious Diseases |
8 | 1.44 |
European Urology |
3 | 0.52 |
Gastroenterology |
1 | 0.29 |
Hepatology |
1 | 0.02 |
JAMA Pediatrics |
1 | 0.07 |
Journal of Clinical Oncology |
3 | 0.36 |
Journal of Infectious Diseases |
2 | 1.28 |
Journal of the American Academy of Dermatology |
1 | 0.31 |
Journal of the American Society of Nephrology |
1 | 0.19 |
Nature |
2 | 0.05 |
Nature Communications |
8 | 3.46 |
Nature Medicine |
7 | 0.94 |
PLOS Medicine |
1 | 0.03 |
Radiology |
1 | 0.10 |
The Journal of Allergy and Clinical Immunology |
1 | 0.55 |
The Lancet |
4 | 0.83 |
The New England Journal of Medicine |
5 | 2.29 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.